文献速递造血干细胞移植与细胞治疗贫血与红细胞疾病

异基因造血干细胞移植治疗五例经典型阵发性睡眠性血红蛋白尿症的临床观察

[Clinical observation of allogeneic hematopoietic stem cell transplantation for treating five cases of classic paroxysmal nocturnal hemoglobinuria].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2024-01-01

2019至2023年5例经典型阵发性睡眠性血红蛋白尿症(cPNH)患者接受异基因造血干细胞移植,均为男性,中位年龄26岁。4例单倍体、1例同胞全相合移植,3例清髓性、2例减低剂量预处理。中位随访16个月,5例PNH克隆均转阴,1例死于复发合并感染,4例存活。

要点

  • 5例cPNH患者移植后PNH克隆均转阴,中位转阴时间移植后2(1~3)个月。
  • 未发生原发性植入失败,中位中性粒细胞植入15(13~21)d,血小板植入24(13~60)d。
  • 3例发生Ⅱ度急性GVHD,2例发生局限型慢性GVHD;中位随访16(6~34)个月,1例死于复发合并感染。

核心结论

  • 5例经典型阵发性睡眠性血红蛋白尿症患者接受异基因造血干细胞移植后PNH克隆均转阴,4例存活。

研究设计与样本

  • 研究纳入2019至2023年在中国医学科学院血液病医院接受异基因造血干细胞移植的5例经典型阵发性睡眠性血红蛋白尿症患者。
  • 5例均为男性,中位年龄26(26~46)岁,诊断到移植中位间隔5.5(3.6~18.0)年。
  • 单倍体移植4例,同胞全相合移植1例;清髓性预处理3例,减低剂量预处理2例。

主要发现

  • 移植前粒细胞中位PNH克隆96.3%(90.0%~99.7%),中位乳酸脱氢酶2 224(1 244~4 753)U/L。
  • 中位中性粒细胞植入时间15(13~21)d,中位血小板植入时间24(13~60)d,未发生原发性植入失败。
  • 3例发生Ⅱ度急性GVHD,无Ⅲ/Ⅳ度急性GVHD;2例发生局限型慢性GVHD,无广泛型慢性GVHD。
  • 5例PNH克隆均转阴,中位转阴时间移植后2(1~3)个月。
  • 中位随访16(6~34)个月,1例死于疾病复发合并感染,存活4例中2例已停用所有药物。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study enrolled five patients with classic paroxysmal nocturnal hemoglobinuria (cPNH) who underwent allogeneic hematopoietic stem cell transplantation in our hospital from 2019 to 2023. All five patients were male, with a median age of 26 (range: 26-46) years. The median time from diagnosis to allo-HSCT was 5.5 (range: 3.6-18.0) years. The median PNH granulocyte clone size was 96.3% (ranged 90.0%-99.7%), and the median lactate dehydrogenase (LDH) level was 2 224 IU/L (8896-fold of the upper limit of normal). All patients were detected to have bone marrow hyperplasia by trephine biopsy. The stem cell source came from four haploidentical donors and one HLA-identical sibling donor. Among the five patients, three underwent myeloablative conditioning (MAC) and two underwent reduced-intensity conditioning (RIC) treatment. None of the patients experienced primary implantation failure. The neutrophil implantation time was 15 (range: 13-21) days, and the platelet implantation time was 24 (range: 13-60) days. The three patients developed grade II acute graft-versus-host disease (aGVHD). No patients developed grade Ⅲ/Ⅳ aGVHD. The two patients developed localized chronic GVHD (cGVHD), and no patients developed extensive cGVHD. PNH clones turned negative in all patients after 2 (range: 1-3) months of transplantation. At a median follow-up of 16 (range: 6-34) months, one patient died of relapse and infection, and the remaining four patients survived, of which two patients had discontinued all drugs. 2019年至2023年期间,5例经典型阵发性睡眠性血红蛋白尿症(cPNH)患者在中国医学科学院血液病医院接受异基因造血干细胞移植。5例患者均为男性,中位年龄26(26~46)岁,诊断到移植的中位间隔时间为5.5(3.6~18.0)年,移植前粒细胞中位PNH克隆为96.3%(90.0%~99.7)%,中位乳酸脱氢酶2 224(1 244~4 753)U/L,骨髓增生活跃至极度活跃。单倍体移植4例,同胞全相合移植1例。清髓性预处理(MAC)3例,减低剂量预处理(RIC)2例。未发生原发性植入失败及移植后早期死亡。中位中性粒细胞植入时间为15(13~21)d,中位血小板植入时间为24(13~60)d。3例患者移植后发生Ⅱ度急性移植物抗宿主病(GVHD),2例患者发生局限型慢性GVHD。5例患者移植后PNH克隆均转阴,中位转阴时间为移植后2(1~3)个月。中位随访16(6~34)个月,1例患者死于疾病复发合并感染。存活的4例患者中,2例已停用所有药物,1例口服环孢素A治疗皮肤慢性GVHD,另外1例口服环孢素A常规预防GVHD。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhao XL, Zhang LN, Zhang XY, et al. [Clinical observation of allogeneic hematopoietic stem cell transplantation for treating five cases of classic paroxysmal nocturnal hemoglobinuria]. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39765354. doi:10.3760/cma.cn121090-20240612-00221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。